Related Experiment Video
Updated: Jul 27, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
ABCA1. The gatekeeper for eliminating excess tissue cholesterol
1Department of Medicine, Box 356426, 1959 NE Pacific Pl., University of Washington, Seattle, WA 98195-6426, USA. joram@u.washington.edu
Insights
The ATP-binding cassette transporter ABCA1 is crucial for removing excess cholesterol from cells, protecting against atherosclerosis. Its function is key to maintaining healthy high-density lipoprotein (HDL) levels and preventing cardiovascular disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Science
Background:
- High-density lipoprotein (HDL) facilitates reverse cholesterol transport, potentially preventing atherosclerosis.
- The ATP-binding cassette transporter ABCA1 initiates reverse cholesterol transport by moving cholesterol and phospholipids to apolipoproteins.
Purpose of the Study:
- To elucidate the role of ABCA1 in cholesterol metabolism and cardiovascular disease.
- To understand the impact of ABCA1 mutations and activity on HDL levels and atherosclerosis.
Main Methods:
- Studied Tangier disease (TD) heterozygotes to assess ABCA1 activity's impact on HDL and cardiovascular disease (CVD).
- Investigated drug-induced ABCA1 modulation in mice to observe effects on cholesterol clearance and absorption.
Main Results:
- ABCA1 mutations cause Tangier disease, a condition marked by cholesterol accumulation in macrophages and atherosclerosis.
- ABCA1 activity significantly influences plasma HDL levels and CVD susceptibility.
- Inducing ABCA1 in mice enhanced cholesterol clearance and reduced intestinal cholesterol absorption.
Conclusions:
- ABCA1 acts as a primary regulator of cellular cholesterol elimination, impacting overall cholesterol metabolism.
- ABCA1 plays a critical role in protecting against cardiovascular disease by managing tissue cholesterol levels.
Abstract:
It is widely believed that HDL functions to transport cholesterol from peripheral cells to the liver by reverse cholesterol transport, a pathway that may protect against atherosclerosis by clearing excess cholesterol from arterial cells. A cellular ATP-binding cassette transporter (ABC) called ABCA1 mediates the first step of reverse cholesterol transport: the transfer of cellular cholesterol and phospholipids to lipid-poor apolipoproteins. Mutations in ABCA1 cause Tangier disease (TD), a severe HDL deficiency syndrome characterized by accumulation of cholesterol in tissue macrophages and prevalent atherosclerosis. Studies of TD heterozygotes revealed that ABCA1 activity is a major determinant of plasma HDL levels and susceptibility to CVD. Drugs that induce ABCA1 in mice increase clearance of cholesterol from tissues and inhibit intestinal absorption of dietary cholesterol. Multiple factors related to lipid metabolism and other processes modulate expression and tissue distribution of ABCA1.Therefore, as the primary gatekeeper for eliminating tissue cholesterol, ABCA1 has a major impact on cellular and whole body cholesterol metabolism and is likely to play an important role in protecting against cardiovascular disease.
Related Concept Videos
Receptor-mediated Endocytosis
Lipid Digestion
ABC Transporters: Exporter
Regulation of Nuclear Protein Sorting
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

